The possibility to target Bcl-2 family members proteins to induce apoptosis in cancer cells has been studied for many years now and particular attention has been given to BH3 only proteins in designing drugs that would mimic their pro-apoptotic functions. This evidence concerns the gene BCL2 and cancer.